Skip to content

SPRING PHARMACEUTICAL GROUP, INC.

CIK 0000847464

← back to feed
Revenue (TTM)
$76.28M
+15.0% YoY Q3 Feb 2019
Net Income (TTM)
$16.17M
+16.7% YoY Q3 Feb 2019
EPS Diluted (TTM)
—
Q3 Feb 2019
Gross Margin
42.7%
Q3 Feb 2019
Operating Margin
28.1%
Q3 Feb 2019
Net Margin
21.2%
Q3 Feb 2019
Free Cash Flow (TTM)
$9.34M
Q3 Feb 2019
Cash
$35.96M
Q3 Feb 2019
Total Debt
—
Q3 Feb 2019
Shares Outstanding
29.84M sh
Q3 Feb 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings